2007
DOI: 10.1016/j.fertnstert.2006.12.077
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy of vaginal danazol treatment in women with recurrent deeply infiltrating endometriosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
43
0
1

Year Published

2007
2007
2024
2024

Publication Types

Select...
5
4

Relationship

2
7

Authors

Journals

citations
Cited by 85 publications
(46 citation statements)
references
References 25 publications
2
43
0
1
Order By: Relevance
“…The safety and high compliance of vaginaladministered danazol agree with previous reports of vaginal administration in perimenopausal women (10,12) and in endometriotic women (11). A danazol-loaded IUD has been shown to be an effective and conservative treatment for dysmenorrhea, pelvic pain, and dyspareunia associated with endometriosis (14).…”
Section: Discussionsupporting
confidence: 86%
See 1 more Smart Citation
“…The safety and high compliance of vaginaladministered danazol agree with previous reports of vaginal administration in perimenopausal women (10,12) and in endometriotic women (11). A danazol-loaded IUD has been shown to be an effective and conservative treatment for dysmenorrhea, pelvic pain, and dyspareunia associated with endometriosis (14).…”
Section: Discussionsupporting
confidence: 86%
“…The use of danazol by vaginal route reduces the adverse side effects. Indeed, vaginal danazol proved to be effective in premenopausal women with AUB related to endometrial hyperplasia or endometrial polyps (12). The same treatment has been tested in a group of postmenopausal women gived vaginal danazol for 10 days every month for 6 months along with continuous transdermal E 2 counteracting the mitogenic effect of estrogen on the endometrium (10), as well as in women with deep infiltrating endometriosis for treating pelvic pain (11).…”
mentioning
confidence: 99%
“…Fedele et al [43] showed that, in women who had previously undergone conservative surgery for endometriosis without excision of deep lesions further treated with levonorgestrel intrauterine device (LNG-IUD), dysmenorrhoea, which had been moderate or severe in all cases, during treatment were absent. Other medical options, such as vaginal danazol (200 mg/day) were also tested on dysmenorrhoea and dyspareunia after surgery for DIE, showing a consistent and significant improvement in painful symptoms [44]. In a recent study of estroprogestin therapy, Mabrouk et al [45] reported that combined oral contraceptive therapy may have a role to play in restraining the progression of dysmenorrhoea and dyspareunia, and the growth of deep endometriotic nodules.…”
Section: Deep Infiltrating Endometriosis Diagnostic Imaging and Implimentioning
confidence: 99%
“…In contrast, vaginally administered danazol improves pain symptoms caused by endometriosis with minimal adverse effects [12,13]. The daily administration of vaginal danazol does not affect the pituitary-ovarian axis [14] and does not inhibit ovulation [15].…”
Section: Introductionmentioning
confidence: 98%